28 February 2022
Showing results for:
21 February 2022
Aducanumab for Alzheimer disease: opinions mixed, cost “crazy”
7 February 2022
Motor neuron disease: the importance of finding biomarkers
24 January 2022
Chaos or community: we need to make a choice
17 January 2022
Chemical restraint regulations: is compliance enough?
11 October 2021
Sarcopenia: the silent muscle-wasting disease
11 October 2021
COVID-19 research news in brief
4 October 2021